Nanotechnology offers promising solutions for the early diagnosis of asthma. Traditional diagnostic methods, such as spirometry, can be cumbersome and not always accurate. Nanotechnology can enable the development of highly sensitive biosensors that can detect specific biomarkers associated with asthma in bodily fluids like blood, urine, or even exhaled breath. These sensors can provide rapid and precise results, facilitating early intervention.
